PharmaShots | Incisive News in 3 Shots

Subscribe Now

Assets

Takeda to Divest OTC and Select Non-core Assets to Celltrion for ~ $278M

Takeda to Divest OTC and Select Non-core Assets to Celltrion for ~ $278M

June 12, 2020

Sandoz to Acquire Aspen's Japanese Operations and Associated Assets for ~$440M

Sandoz to Acquire Aspen's Japanese Operations and Associated Assets for ~$440M

November 11, 2019

Biocon Biologics Signs an In-License Agreement with Just - Evotec Biologics

Biocon Biologics Signs an In-License Agreement with Just - Evotec Biologics

October 11, 2019

Varian to Acquire Boston Scientific's Oncology Assets for $90M

Varian to Acquire Boston Scientific's Oncology Assets for $90M

July 2, 2019

Valneva Terminates its Agreement with GSK for Regaining Control of Research and Development Assets

Valneva Terminates its Agreement with GSK for Regaining Control of Research and Development Assets

June 21, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us